Skip to content
2000
  1. Home
  2. A-Z Publications
  3. The International Journal of Gastroenterology and Hepatology Diseases
  4. Volume 1, Issue 1
  5. Article
Volume 1, Issue 1
  • ISSN: 2666-2906
  • E-ISSN: 2666-2914

Abstract

Budd-Chiari Syndrome (BCS) is characterized by significant clinical and pathophysiological aspects that seem to allow a sharp differentiation between a variant in the West from one in the East.

The aim of this paper is to focus on the main issues and controversies about the management of BCS in the West. The study discusses different treatment options and how research is trying to solve controversies about debated topics, such as the timing of treatment. In fact, guidelines regarding management of BCS suggest a step-wise strategy starting with medical therapy, arriving at revascularization or TIPS as the second step, and culminating to liver transplant as rescue therapy.

However, long-term outcome is frequently dismal on sole medical therapy. In fact, it is a matter of debate whether further intervention should be suggested only when hemodynamic consequences of portal hypertension are evident. However, as recently hypothesized, chronic micro-vascular ischemia due to impaired venous hepatic outflow could trigger liver fibrosis, resulting in portal hypertension and progressive liver failure. Consequently, liver congestion relief through treatment might be useful as a preventive tool. Recently, early TIPS proved to improve BCS outcome. A direct comparison of early intervention versus step-wise strategy would seem advisable. Furthermore, further studies should address whether non-invasive tools could predict which patients benefit from early intervention.

© 2022 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ijghd/10.2174/2666290601666210406162525
2022-04-01
2024-11-22

  • From This Site

    /content/journals/ijghd/10.2174/2666290601666210406162525
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. MancusoA. Timing of TIPS in Budd Chiari syndrome: an Italian Hepatologist’s perspective.J. Transl. Int. Med.20175419419910.1515/jtim‑2017‑003329340275
     [Google Scholar]
  2. DeLeveL.D. VallaD.C. Garcia-TsaoG. American association for the study liver diseases. Vascular Disorders Of The Liver.Hepatology20094951729176410.1002/hep.2277219399912
     [Google Scholar]
  3. MancusoA. Budd-Chiari syndrome management: Lights and shadows.World J. Hepatol.201131026226410.4254/wjh.v3.i10.26222059108
     [Google Scholar]
  4. MancusoA. An update on management of Budd-Chiari syndrome.Ann. Hepatol.201413332332610.1016/S1665‑2681(19)30860‑924756006
     [Google Scholar]
  5. Garcia-PagánJ.C. BuscariniE. JanssenH.L.A. European Association for the Study of the Liver. Electronic address: [email protected]. EASL clinical practice guidelines: vascular diseases of the liver.J. Hepatol.201664117920210.1016/j.jhep.2015.07.04026516032
     [Google Scholar]
  6. QiX. HanG. GuoX. De StefanoV. XuK. LuZ. XuH. MancusoA. ZhangW. HanX. VallaD.C. FanD. Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China.Aliment. Pharmacol. Ther.20164411-121152116710.1111/apt.1381527734511
     [Google Scholar]
  7. MancusoA. Budd-chiari syndrome in the West and the East: Same syndrome, different diseases.Liver Int.201939122417241910.1111/liv.1413131066181
     [Google Scholar]
  8. BargallóX. GilabertR. NicolauC. García-PagánJ.C. AyusoJ.R. BrúC. Sonography of Budd-chiari syndrome.AJR Am. J. Roentgenol.20061871W33-4110.2214/AJR.04.091816794137
     [Google Scholar]
  9. Van, Wettere Imaging in Budd–Chiari syndrome. In:Budd-Chiari SyndromeXingshun, Qi, Ed.; Springer Nature: Singapore, 2020; pp. 39-55.
     [Google Scholar]
  10. GuptaP. BansalV. Kumar-MP. SinhaS.K. SamantaJ. MandavdhareH. SharmaV. DuttaU. KochharR. Diagnostic accuracy of Doppler ultrasound, CT and MRI in Budd Chiari syndrome: systematic review and meta-analysis.Br. J. Radiol.20209311092019084710.1259/bjr.2019084732150462
     [Google Scholar]
  11. MancusoA. ButeraG. PolitiF. MaringhiniA. Budd Chiari syndrome presenting with hepatic transient mosaic enhancement pattern and treated with early TIPS.AME Med. J.201726010.21037/amj.2017.05.12
     [Google Scholar]
  12. RonotM. KerbaolA. RautouP.E. BrancatelliG. BedossaP. Cazals-HatemD. VallaD.C. VilgrainV. Acute extrahepatic infectious or inflammatory diseases are a cause of transient mosaic pattern on CT and MR imaging related to sinusoidal dilatation of the liver.Eur. Radiol.20162693094310110.1007/s00330‑015‑4124‑226615556
     [Google Scholar]
  13. MancusoA. Agreed diagnostic criteria needed for Budd-Chiari syndrome.Br. J. Radiol.20209311102020025910.1259/bjr.2020025932310674
     [Google Scholar]
  14. NawelA. NabilD. Hepatocellular carcinoma in Budd-Chiari syndrome. In: Budd-Chiari Syndrome. QiX. SingaporeSpringer Nature2020113129
     [Google Scholar]
  15. Van WettereM. PurcellY. BrunoO. PayancéA. PlessierA. RautouP.E. Cazals-HatemD. VallaD. VilgrainV. RonotM. Low specificity of washout to diagnose hepatocellular carcinoma in nodules showing arterial hyperenhancement in patients with Budd-Chiari syndrome.J. Hepatol.20197061123113210.1016/j.jhep.2019.01.00930654065
     [Google Scholar]
  16. MancusoA. Management of hepatocellular carcinoma: Enlightening the gray zones.World J. Hepatol.20135630231010.4254/wjh.v5.i6.30223805354
     [Google Scholar]
  17. DangX. LiL. LiS. WangY. LiH. XuS. XuP. Studies on Budd-chiari syndrome complicated with hepatocellular carcinoma: most patients without inferior vena cava obstruction.Int. J. Clin. Exp. Med.2015869071907826309561
     [Google Scholar]
  18. PaulS.B. Shalimar; Sreenivas, V.; Gamanagatti, S.R.; Sharma, H.; Dhamija, E.; Acharya, S.K. Incidence and risk factors of hepatocellular carcinoma in patients with hepatic venous outflow tract obstruction.Aliment. Pharmacol. Ther.2015411096197110.1111/apt.1317325809735
     [Google Scholar]
  19. LiuF.Y. WangM.Q. DuanF. FanQ.S. SongP. WangY. Hepatocellular carcinoma associated with Budd-Chiari syndrome: imaging features and transcatheter arterial chemoembolization.BMC Gastroenterol.20131310510.1186/1471‑230X‑13‑10523800233
     [Google Scholar]
  20. ParkH. YoonJ.Y. ParkK.H. KimD.Y. AhnS.H. HanK.H. ChonC.Y. ParkJ.Y. Hepatocellular carcinoma in Budd-Chiari syndrome: a single center experience with long-term follow-up in South Korea.World J. Gastroenterol.201218161946195210.3748/wjg.v18.i16.194622563176
     [Google Scholar]
  21. GwonD.I.I. KoG.Y. YoonH.K. SungK.B. KimJ.H. LeeS.S. LeeJ.M. OhmJ.Y. ShinJ.H. SongH.Y. Hepatocellular carcinoma associated with membranous obstruction of the inferior vena cava: incidence, characteristics, and risk factors and clinical efficacy of TACE.Radiology2010254261762610.1148/radiol.0909073820093533
     [Google Scholar]
  22. MoucariR. RautouP.E. Cazals-HatemD. GearaA. BureauC. ConsignyY. FrancozC. DenningerM.H. VilgrainV. BelghitiJ. DurandF. VallaD. PlessierA. Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors.Gut200857682883510.1136/gut.2007.13947718218675
     [Google Scholar]
  23. MancusoA. An update on the management of Budd-Chiari syndrome: the issues of timing and choice of treatment.Eur. J. Gastroenterol. Hepatol.201527320020310.1097/MEG.000000000000028225590783
     [Google Scholar]
  24. SeijoS. PlessierA. HoekstraJ. Dell’eraA. MandairD. RifaiK. TrebickaJ. MorardI. LasserL. AbraldesJ.G. Darwish MuradS. HellerJ. HadengueA. PrimignaniM. EliasE. JanssenH.L. VallaD.C. Garcia-PaganJ.C. European network for vascular disorders of the liver. Good long-term outcome of Budd-Chiari syndrome with a step-wise management.Hepatology20135751962196810.1002/hep.2630623389867
     [Google Scholar]
  25. RautouP.E. DouarinL. DenningerM.H. EscolanoS. LebrecD. MoreauR. VidaudM. ItzyksonR. MoucariR. BezeaudA. VallaD. PlessierA. Bleeding in patients with Budd-Chiari syndrome.J. Hepatol.2011541566310.1016/j.jhep.2010.06.01920889223
     [Google Scholar]
  26. WanlessI.R. WongF. BlendisL.M. GreigP. HeathcoteE.J. LevyG. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension.Hepatology1995215123812477737629
     [Google Scholar]
  27. PanS. KleppeL.S. WittT.A. MueskeC.S. SimariR.D. The effect of vascular smooth muscle cell-targeted expression of tissue factor pathway inhibitor in a murine model of arterial thrombosis.Thromb. Haemost.200492349550210.1160/TH04‑01‑000615351845
     [Google Scholar]
  28. MancusoA. Cirrhosis development probably arises from chronic micro-vascular ischemia.Med. Hypotheses201482224410.1016/j.mehy.2013.11.04424389105
     [Google Scholar]
  29. MancusoA. The ischemic liver cirrhosis theory and its clinical implications.Med. Hypotheses2016944610.1016/j.mehy.2016.06.00827515188
     [Google Scholar]
  30. SimonettoD.H. YangH.Y. YinM. Chronic passive venous congestion drives hepatic fibro-genesis via sinusoidal thrombosis and mechanical forces.Hepatology20156164965910.1002/hep.27387
     [Google Scholar]
  31. MancusoA. Letter: Target of TIPSS for Budd-Chiari syndrome should be avoiding liver transplant.Aliment. Pharmacol. Ther.20143911134210.1111/apt.1273824803257
     [Google Scholar]
  32. MancusoA. TIPS for Budd-Chiari syndrome: time to anticipate treatment.Liver Int.2014347e32510.1111/liv.1254424650135
     [Google Scholar]
  33. MancusoA. Budd-chiari syndrome management: Timing of treatment is an open issue.Hepatology2014593121310.1002/hep.2661923857382
     [Google Scholar]
  34. MancusoA. Limits of evidence based medicine for rare diseases: The case of Budd-chiari syndrome.Dig. Liver Dis.201648668910.1016/j.dld.2016.02.02527005858
     [Google Scholar]
  35. PlessierA. SibertA. ConsignyY. HakimeA. ZappaM. DenningerM.H. CondatB. FargesO. ChagneauC. de LedinghenV. FrancozC. SauvanetA. VilgrainV. BelghitiJ. DurandF. VallaD. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome.Hepatology20064451308131610.1002/hep.2135417058215
     [Google Scholar]
  36. De GottardiA. TrebickaJ. KlingerC. PlessierA. SeijoS. TerziroliB. MagentaL. SemelaD. BuscariniE. LangletP. GörtzenJ. PuenteA. MüllhauptB. NavascuèsC. NeryF. DeltenreP. TuronF. EngelmannC. AryaR. CacaK. Peck-RadosavljevicM. LeebeekF.W.G. VallaD. Garcia-PaganJ.C. InvestigatorsV.A.L.D.I.G. VALDIG InvestigatorsAntithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.Liver Int.201737569469910.1111/liv.1328527778440
     [Google Scholar]
  37. BilbaoJ.I. PueyoJ.C. LongoJ.M. AriasM. HerreroJ.I. BenitoA. BarettinoM.D. PerottiJ.P. PardoF. Interventional therapeutic techniques in Budd-Chiari syndrome.Cardiovasc. Intervent. Radiol.199720211211910.1007/s0027099001179030501
     [Google Scholar]
  38. FisherN.C. McCaffertyI. DolapciM. WaliM. BuckelsJ.A. OlliffS.P. EliasE. Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting.Gut199944456857410.1136/gut.44.4.56810075967
     [Google Scholar]
  39. EapenC.E. VelissarisD. HeydtmannM. GunsonB. OlliffS. EliasE. Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome.Gut200655687888410.1136/gut.2005.07142316174658
     [Google Scholar]
  40. WangQ. LiK. HeC. YuanX. LuoB. QiX. GuoW. BaiW. YuT. FanJ. WangZ. YuanJ. LiX. ZhuY. HanN. NiuJ. LvY. LiuL. LiJ. TangS. GuoS. WangE. XiaD. WangZ. CaiH. WangJ. YinZ. XiaJ. FanD. HanG. Angioplasty with versus without routine stent placement for Budd-Chiari syndrome: a randomised controlled trial.Lancet Gastroenterol. Hepatol.20194968669710.1016/S2468‑1253(19)30177‑331279647
     [Google Scholar]
  41. PerellóA. García-PagánJ.C. GilabertR. SuárezY. MoitinhoE. CervantesF. ReverterJ.C. EscorsellA. BoschJ. RodésJ. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy.Hepatology200235113213910.1053/jhep.2002.3027411786969
     [Google Scholar]
  42. MancusoA. FungK. MelaM. TibballsJ. WatkinsonA. BurroughsA.K. PatchD. TIPS for acute and chronic Budd-Chiari syndrome: a single-centre experience.J. Hepatol.200338675175410.1016/S0168‑8278(03)00118‑112763367
     [Google Scholar]
  43. RössleM. OlschewskiM. SiegerstetterV. BergerE. KurzK. GrandtD. The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt.Surgery2004135439440310.1016/j.surg.2003.09.00515041963
     [Google Scholar]
  44. MancusoA. WatkinsonA. TibballsJ. PatchD. BurroughsA.K. Budd-Chiari syndrome with portal, splenic, and superior mesenteric vein thrombosis treated with TIPS: who dares wins.Gut200352343810.1136/gut.52.3.43812584231
     [Google Scholar]
  45. Darwish MuradS. VallaD.C. de GroenP.C. ZeitounG. HaagsmaE.B. KuipersE.J. JanssenH.L. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis.Am. J. Gastroenterol.20061011839010.1111/j.1572‑0241.2006.00353.x16405538
     [Google Scholar]
  46. Garcia-PagánJ.C. HeydtmannM. RaffaS. PlessierA. MuradS. FabrisF. VizziniG. Gonzales AbraldesJ. OlliffS. NicoliniA. LucaA. PrimignaniM. JanssenH.L. VallaD. EliasE. BoschJ. Budd-Chiari Syndrome-Transjugular Intrahepatic Portosystemic Shunt GroupTIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients.Gastroenterology2008135380881510.1053/j.gastro.2008.05.05118621047
     [Google Scholar]
  47. QiX. GuoW. HeC. ZhangW. WuF. YinZ. BaiM. NiuJ. YangZ. FanD. HanG. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: techniques, indications and results on 51 Chinese patients from a single centre.Liver Int.20143481164117510.1111/liv.1235524256572
     [Google Scholar]
  48. TripathiD. MacnicholasR. KothariC. SunderrajL. Al-HilouH. RangarajanB. ChenF. MangatK. EliasE. OlliffS. Good clinical outcomes following transjugular intrahepatic portosystemic stent-shunts in Budd-Chiari syndrome.Aliment. Pharmacol. Ther.201439886487210.1111/apt.1266824611957
     [Google Scholar]
  49. RingeB. LangH. OldhaferK.J. GebelM. FlemmingP. GeorgiiA. BorstH.G. PichlmayrR. Which is the best surgery for Budd-Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients.Hepatology19952151337134410.1002/hep.18402105187737640
     [Google Scholar]
  50. HemmingA.W. LangerB. GreigP. TaylorB.R. AdamsR. HeathcoteE.J. Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation.Am. J. Surg.1996171117618010.1016/S0002‑9610(99)80095‑68554136
     [Google Scholar]
  51. OrloffM.J. IsenbergJ.I. WheelerH.O. DailyP.O. GirardB. Budd-Chiari syndrome revisited: 38 years’ experience with surgical portal decompression.J. Gastrointest. Surg.201216228630010.1007/s11605‑011‑1738‑922065317
     [Google Scholar]
  52. ZhangY. ZhaoH. YanD. XueH. LauW.Y. Superior mesenteric vein-caval-right atrium Y shunt for treatment of Budd-Chiari syndrome with obstruction to the inferior vena cava and the hepatic veins--a study of 62 patients.J. Surg. Res.20111691e93e9910.1016/j.jss.2011.02.03021529832
     [Google Scholar]
  53. MancusoA. MartinelliL. De CarlisL. RampoldiA.G. MagentaG. CannataA. BelliL.S. A caval homograft for Budd-Chiari syndrome due to inferior vena cava obstruction.World J. Hepatol.20135529229510.4254/wjh.v5.i5.29223717741
     [Google Scholar]
  54. SrinivasB.C. DattatreyaP.V. SrinivasaK.H. PrabhavathiC.N. ManjunathC.N. Inferior vena cava obstruction: long-term results of endovascular management.Indian Heart J.201264216216910.1016/S0019‑4832(12)60054‑622572493
     [Google Scholar]
  55. LiQ. ZhangT. WangD. LiW. ZhangX. ZhangX. Radical surgical treatment of Budd-Chiari syndrome through entire exposure of hepatic inferior vena cava.J. Vasc. Surg. Venous Lymphat. Disord.201971748110.1016/j.jvsv.2018.02.00730341019
     [Google Scholar]
  56. HalffG. TodoS. TzakisA.G. GordonR.D. StarzlT.E. Liver transplantation for the Budd-Chiari syndrome.Ann. Surg.19902111434910.1097/00000658‑199001000‑000072294842
     [Google Scholar]
  57. RaoA.R. ChuiA.K. GurkhanA. ShiL.W. Al-HarbiI. WaughR. VerranD.J. McCaughanG.W. KooreyD. SheilA.G. Orthotopic liver transplantation for treatment of patients with Budd-Chiari syndrome: a Singe-center experience.Transplant. Proc.20003272206220710.1016/S0041‑1345(00)01636‑511120134
     [Google Scholar]
  58. UlrichF. SteinmüllerT. LangM. SettmacherU. MüllerA.R. JonasS. TulliusS.G. NeuhausP. Liver transplantation in patients with advanced Budd-Chiari syndrome.Transplant. Proc.2002346227810.1016/S0041‑1345(02)03234‑712270397
     [Google Scholar]
  59. SrinivasanP. RelaM. PrachaliasA. MuiesanP. PortmannB. MuftiG.J. PagliucaA. O’GradyJ. HeatonN. Liver transplantation for Budd-Chiari syndrome.Transplantation200273697397710.1097/00007890‑200203270‑0002611923703
     [Google Scholar]
  60. MenthaG. GiostraE. MajnoP.E. BechsteinW.O. NeuhausP. O’GradyJ. PraseedomR.K. BurroughsA.K. Le TreutY.P. KirkegaardP. RogiersX. EriczonB.G. HockerstedtK. AdamR. KlempnauerJ. Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centres.J. Hepatol.200644352052810.1016/j.jhep.2005.12.00216427719
     [Google Scholar]
  61. SegevD.L. NguyenG.C. LockeJ.E. SimpkinsC.E. MontgomeryR.A. MaleyW.R. ThuluvathP.J. Twenty years of liver transplantation for Budd-Chiari syndrome: a national registry analysis.Liver Transpl.20071391285129410.1002/lt.2122017763380
     [Google Scholar]
  62. PotthoffA. AttiaD. PischkeS. MederackeI. BeutelG. RifaiK. DeterdingK. HeiringhoffK. KlempnauerJ. StrassburgC.P. MannsM.P. BahrM.J. Long-term outcome of liver transplant patients with Budd-Chiari syndrome secondary to myeloproliferative neoplasms.Liver Int.20153582042204910.1111/liv.1281625736096
     [Google Scholar]
  63. MancusoA. Time to resize the role of liver transplant for Budd-Chiari syndrome.Liver Int.20153510233910.1111/liv.1282825790310
     [Google Scholar]
  64. AlukalJ.J. ZhangT. ThuluvathP.J. Outcomes of status 1 liver transplantation for Budd-Chiari Syndrome with fulminant hepatic failure.Am. J. Transplant.IN PRESS33236517
     [Google Scholar]
  65. ChoiG.S. ParkJ.B. JungG.O. ChunJ.M. KimJ.M. MoonJ.I. KwonC.H. KimS.J. JohJ.W. LeeS.K. Living donor liver transplantation in Budd-Chiari syndrome: a single-center experience.Transplant. Proc.201042383984210.1016/j.transproceed.2010.02.04520430186
     [Google Scholar]
  66. YoonY.I. LeeS.G. MoonD.B. AhnC.S. HwangS. KimK.H. HaT.Y. SongG.W. JungD.H. ParkG.C. KimD.S. ChooS.J. Surgical techniques and long-term outcomes of living-donor liver transplantation with inferior vena cava replacement using atriocaval synthetic interposition graft for Budd-Chiari syndrome.Ann. Surg.20192694e43e4510.1097/SLA.000000000000284730080720
     [Google Scholar]
  67. Darwish MuradS. PlessierA. Hernandez-GuerraM. FabrisF. EapenC.E. BahrM.J. TrebickaJ. MorardI. LasserL. HellerJ. HadengueA. LangletP. MirandaH. PrimignaniM. EliasE. LeebeekF.W. RosendaalF.R. Garcia-PaganJ.C. VallaD.C. JanssenH.L. EN-Vie (European Network for Vascular Disorders of the Liver). Etiology, management, and outcome of the Budd-Chiari syndrome.Ann. Intern. Med.2009151316717510.7326/0003‑4819‑151‑3‑200908040‑0000419652186
     [Google Scholar]
  68. QiX. RenW. WangY. GuoX. FanD. Survival and prognostic indicators of Budd-Chiari syndrome: a systematic review of 79 studies.Expert Rev. Gastroenterol. Hepatol.20159686587510.1586/17474124.2015.102422425754880
     [Google Scholar]
  69. MancusoA. Management of Budd-Chiari syndrome in children: same debated issues as in adults.Eur. J. Gastroenterol. Hepatol.201527110710810.1097/MEG.000000000000023225426986
     [Google Scholar]
  70. MancusoA. Outcome of Budd-Chiari syndrome in Behçetys syndrome.Semin. Arthritis Rheum.2015451e110.1016/j.semarthrit.2015.04.00425953713
     [Google Scholar]
  71. HeF. ZhaoH. DaiS. WuY. WangL. HuangH. YueZ. FanZ. DongX. LiuF. Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome with diffuse occlusion of hepatic veins.Sci. Rep.201663638010.1038/srep3638027805025
     [Google Scholar]
  72. RosenqvistK. SheikhiR. ErikssonL.G. RajaniR. RorsmanF. SangfeltP. NymanR. Endovascular treatment of symptomatic Budd-Chiari syndrome - in favour of early transjugular intrahepatic portosystemic shunt.Eur. J. Gastroenterol. Hepatol.201628665666010.1097/MEG.000000000000062126958788
     [Google Scholar]
  73. WangH.W. ShiH.N. ChengJ. XieF. LuoY.K. TangJ. Real-time shear wave elastography (SWE) assessment of short- and long-term treatment outcome in Budd-Chiari syndrome: A pilot study.PLoS One2018135e019755010.1371/journal.pone.019755029847588
     [Google Scholar]
  74. SuL. HuL. LiangP. WuY. SunQ. GaoJ. Clinical efficacy of spectral computed tomography for evaluating liver function in patients with Budd-Chiari syndrome.Acad. Radiol.201926446146610.1016/j.acra.2018.05.00330098862
     [Google Scholar]
  75. MancusoA. Controversies in the management of Budd-chiari syndrome. In: Budd-Chiari Syndrome. QiX. SingaporeSpringer Nature202024525210.1007/978‑981‑32‑9232‑1_19
     [Google Scholar]
  76. MancusoA. AmataM. PolitiF. MitraM. MarsalaM.G.L. MaringhiniA. Controversies in Budd-Chiari syndrome management: potential role of liver stiffness.Am. J. Gastroenterol.2020115695295310.14309/ajg.000000000000058632287138
     [Google Scholar]
  77. HoH. QiuC. Hemodynamic aspects of the Budd-Chiari syndrome of the liver: A computational model study.Med. Eng. Phys.201969134-139. Hemodynamic aspects of the Budd-Chiari syndrome of the liver: A computational model study.10.1016/j.medengphy.2019.04.01031078370
     [Google Scholar]
  78. Mancuso, A. Med. Eng. Phys., 2019, 9, 71. https://www.ncbi.nlm.nih.gov/pubmed/31324448\h
/content/journals/ijghd/10.2174/2666290601666210406162525
Loading
Focusing the Controversies in Budd-Chiari Syndrome Management
Int J Gastroenterol Hepatol Dis 1, e090721192714 (2022); https://doi.org/10.2174/2666290601666210406162525
/content/journals/ijghd/10.2174/2666290601666210406162525
/content/journals/ijghd/10.2174/2666290601666210406162525
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Budd-Chiari syndrome; diagnosis; hepatocellular carcinoma; liver transplant; outcome; TIPS

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test